Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.

Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.

Detalhes bibliográficos
Autor principal:	Matthews, DR
Formato:	Journal article
Idioma:	English
Publicado em:	2011